Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population
-
2012/06/01
Details
-
Personal Author:
-
Description:PURPOSE: To evaluate the impact of ocular surface symptoms on quality of life in a veteran population receiving eye care services. DESIGN: Cross-sectional survey study. METHODS: Setting: Miami Veterans Affairs Medical Center (VAMC). Patient Population: Patients seen at the eye clinic between June and August 2010 were asked to fill out the Dry Eye Questionnaire 5 (DEQ5) and the Impact of Dry Eye on Everyday Life (IDEEL) questionnaire. Main Outcome Measures: Correlation between ocular surface symptoms and functionality. RESULTS: Four hundred eighty-nine patients elected to fill out the DEQ5 questionnaire (36% response rate). The mean age of respondents was 66 years (standard deviation 12). Ninety-four percent were male; 62% were white and 37% were black. Using the DEQ5 as a surrogate measure of ocular surface symptoms, 65% of respondents reported at least mild ocular surface symptoms (DEQ5 =6) and 27% of them reported severe symptoms (DEQ5 =12). Black subjects had a 2-fold increased risk of severe symptoms compared to white subjects (odds ratio 2.06, 95% confidence interval 1.33-3.19). Several medications were associated with a significantly increased risk of severe symptoms, including glaucoma medications (1.7-fold increase), antidepressants (2.3-fold increase), and antihistamines (2.1-fold increase). There was an inverse correlation between DEQ5 and IDEEL scores with regard to ability to perform activities of daily living (n = 391, r = -0.54, P < .001), emotional well-being (n = 386, r = -0.63, P < .001), and the ability to work (n = 205, r = -0.57, P < .001). Fifty percent of patients with severe symptoms had documentation that their symptoms were addressed during the visit. CONCLUSION: Severe ocular surface symptoms reduce the quality of life of Miami VAMC veterans. Eye care professionals should be vigilant in eliciting ocular surface complaints from their patients. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0002-9394
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:153
-
Issue:6
-
NIOSHTIC Number:nn:20041305
-
Citation:Am J Ophthalmol Jun; 153(6):1061-1066.e3
-
Contact Point Address:Anat Galor, 900 NW 17th St, Miami, FL 33136
-
Email:agalor@med.miami.edu
-
Federal Fiscal Year:2012
-
Performing Organization:University of Miami School of Medicine
-
Peer Reviewed:True
-
Start Date:20020901
-
Source Full Name:American Journal of Ophthalmology
-
End Date:20130831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b67940e2e5fe3d2def321c2725c0336814e998f30b20d4d445cd2578e649ad4cda53084f19e009ae4316d8b13569ed46046adb92de8224b4ebdcf3e27f938ff7
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like